Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer's disease

Abstract Background Despite being a brain disorder, Alzheimer's disease (AD) is often accompanied by peripheral organ dysregulations (e.g., loss of bladder control in late‐stage AD), which highly rely on spinal cord coordination. However, the causal factor(s) for peripheral organ dysregulation...

Full description

Bibliographic Details
Main Authors: Sijia He, Shulan Qiu, Meixia Pan, Juan P. Palavicini, Hu Wang, Xin Li, Anindita Bhattacharjee, Savannah Barannikov, Kevin F. Bieniek, Jeffrey L. Dupree, Xianlin Han
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Clinical and Translational Medicine
Subjects:
Online Access:https://doi.org/10.1002/ctm2.1332
_version_ 1797771135354404864
author Sijia He
Shulan Qiu
Meixia Pan
Juan P. Palavicini
Hu Wang
Xin Li
Anindita Bhattacharjee
Savannah Barannikov
Kevin F. Bieniek
Jeffrey L. Dupree
Xianlin Han
author_facet Sijia He
Shulan Qiu
Meixia Pan
Juan P. Palavicini
Hu Wang
Xin Li
Anindita Bhattacharjee
Savannah Barannikov
Kevin F. Bieniek
Jeffrey L. Dupree
Xianlin Han
author_sort Sijia He
collection DOAJ
description Abstract Background Despite being a brain disorder, Alzheimer's disease (AD) is often accompanied by peripheral organ dysregulations (e.g., loss of bladder control in late‐stage AD), which highly rely on spinal cord coordination. However, the causal factor(s) for peripheral organ dysregulation in AD remain elusive. Methods The central nervous system (CNS) is enriched in lipids. We applied quantitative shotgun lipidomics to determine lipid profiles of human AD spinal cord tissues. Additionally, a CNS sulfatide (ST)‐deficient mouse model was used to study the lipidome, transcriptome and peripheral organ phenotypes of ST loss. Results We observed marked myelin lipid reduction in the spinal cord of AD subjects versus cognitively normal individuals. Among which, levels of ST, a myelin‐enriched lipid class, were strongly and negatively associated with the severity of AD. A CNS myelin‐specific ST‐deficient mouse model was used to further identify the causes and consequences of spinal cord lipidome changes. Interestingly, ST deficiency led to spinal cord lipidome and transcriptome profiles highly resembling those observed in AD, characterized by decline of multiple myelin‐enriched lipid classes and enhanced inflammatory responses, respectively. These changes significantly disrupted spinal cord function and led to substantial enlargement of urinary bladder in ST‐deficient mice. Conclusions Our study identified CNS ST deficiency as a causal factor for AD‐like lipid dysregulation, inflammation response and ultimately the development of bladder disorders. Targeting to maintain ST levels may serve as a promising strategy for the prevention and treatment of AD‐related peripheral disorders.
first_indexed 2024-03-12T21:33:10Z
format Article
id doaj.art-0d768f66a1884131945072162b73e1a2
institution Directory Open Access Journal
issn 2001-1326
language English
last_indexed 2024-03-12T21:33:10Z
publishDate 2023-07-01
publisher Wiley
record_format Article
series Clinical and Translational Medicine
spelling doaj.art-0d768f66a1884131945072162b73e1a22023-07-27T15:20:29ZengWileyClinical and Translational Medicine2001-13262023-07-01137n/an/a10.1002/ctm2.1332Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer's diseaseSijia He0Shulan Qiu1Meixia Pan2Juan P. Palavicini3Hu Wang4Xin Li5Anindita Bhattacharjee6Savannah Barannikov7Kevin F. Bieniek8Jeffrey L. Dupree9Xianlin Han10Barshop Institute for Longevity and Aging Studies University of Texas Health San Antonio San AntonioTexasUSABarshop Institute for Longevity and Aging Studies University of Texas Health San Antonio San AntonioTexasUSABarshop Institute for Longevity and Aging Studies University of Texas Health San Antonio San AntonioTexasUSABarshop Institute for Longevity and Aging Studies University of Texas Health San Antonio San AntonioTexasUSABarshop Institute for Longevity and Aging Studies University of Texas Health San Antonio San AntonioTexasUSABarshop Institute for Longevity and Aging Studies University of Texas Health San Antonio San AntonioTexasUSABarshop Institute for Longevity and Aging Studies University of Texas Health San Antonio San AntonioTexasUSADepartment of Pathology Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases University of Texas Health San Antonio San AntonioTexasUSADepartment of Pathology Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases University of Texas Health San Antonio San AntonioTexasUSADepartment of Anatomy and Neurobiology Virginia Commonwealth University RichmondVirginiaUSABarshop Institute for Longevity and Aging Studies University of Texas Health San Antonio San AntonioTexasUSAAbstract Background Despite being a brain disorder, Alzheimer's disease (AD) is often accompanied by peripheral organ dysregulations (e.g., loss of bladder control in late‐stage AD), which highly rely on spinal cord coordination. However, the causal factor(s) for peripheral organ dysregulation in AD remain elusive. Methods The central nervous system (CNS) is enriched in lipids. We applied quantitative shotgun lipidomics to determine lipid profiles of human AD spinal cord tissues. Additionally, a CNS sulfatide (ST)‐deficient mouse model was used to study the lipidome, transcriptome and peripheral organ phenotypes of ST loss. Results We observed marked myelin lipid reduction in the spinal cord of AD subjects versus cognitively normal individuals. Among which, levels of ST, a myelin‐enriched lipid class, were strongly and negatively associated with the severity of AD. A CNS myelin‐specific ST‐deficient mouse model was used to further identify the causes and consequences of spinal cord lipidome changes. Interestingly, ST deficiency led to spinal cord lipidome and transcriptome profiles highly resembling those observed in AD, characterized by decline of multiple myelin‐enriched lipid classes and enhanced inflammatory responses, respectively. These changes significantly disrupted spinal cord function and led to substantial enlargement of urinary bladder in ST‐deficient mice. Conclusions Our study identified CNS ST deficiency as a causal factor for AD‐like lipid dysregulation, inflammation response and ultimately the development of bladder disorders. Targeting to maintain ST levels may serve as a promising strategy for the prevention and treatment of AD‐related peripheral disorders.https://doi.org/10.1002/ctm2.1332Alzheimer's diseasebladderlipidomespinal cordsulfatide
spellingShingle Sijia He
Shulan Qiu
Meixia Pan
Juan P. Palavicini
Hu Wang
Xin Li
Anindita Bhattacharjee
Savannah Barannikov
Kevin F. Bieniek
Jeffrey L. Dupree
Xianlin Han
Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer's disease
Clinical and Translational Medicine
Alzheimer's disease
bladder
lipidome
spinal cord
sulfatide
title Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer's disease
title_full Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer's disease
title_fullStr Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer's disease
title_full_unstemmed Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer's disease
title_short Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer's disease
title_sort central nervous system sulfatide deficiency as a causal factor for bladder disorder in alzheimer s disease
topic Alzheimer's disease
bladder
lipidome
spinal cord
sulfatide
url https://doi.org/10.1002/ctm2.1332
work_keys_str_mv AT sijiahe centralnervoussystemsulfatidedeficiencyasacausalfactorforbladderdisorderinalzheimersdisease
AT shulanqiu centralnervoussystemsulfatidedeficiencyasacausalfactorforbladderdisorderinalzheimersdisease
AT meixiapan centralnervoussystemsulfatidedeficiencyasacausalfactorforbladderdisorderinalzheimersdisease
AT juanppalavicini centralnervoussystemsulfatidedeficiencyasacausalfactorforbladderdisorderinalzheimersdisease
AT huwang centralnervoussystemsulfatidedeficiencyasacausalfactorforbladderdisorderinalzheimersdisease
AT xinli centralnervoussystemsulfatidedeficiencyasacausalfactorforbladderdisorderinalzheimersdisease
AT aninditabhattacharjee centralnervoussystemsulfatidedeficiencyasacausalfactorforbladderdisorderinalzheimersdisease
AT savannahbarannikov centralnervoussystemsulfatidedeficiencyasacausalfactorforbladderdisorderinalzheimersdisease
AT kevinfbieniek centralnervoussystemsulfatidedeficiencyasacausalfactorforbladderdisorderinalzheimersdisease
AT jeffreyldupree centralnervoussystemsulfatidedeficiencyasacausalfactorforbladderdisorderinalzheimersdisease
AT xianlinhan centralnervoussystemsulfatidedeficiencyasacausalfactorforbladderdisorderinalzheimersdisease